Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,923 | -1,821 | -2,661 | -2,658 | -2,026 |
| Depreciation Amortization | N/A | 0 | 2 | 2 | 2 |
| Accounts payable and accrued liabilities | 188 | 242 | 81 | 19 | 178 |
| Other Working Capital | 1,138 | 417 | 473 | 167 | 439 |
| Other Operating Activity | 57,192 | 225 | 1,000 | 1,034 | 261 |
| Operating Cash Flow | $-405 | $-935 | $-1,105 | $-1,436 | $-1,145 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 886 | 982 | 590 | 767 | 325 |
| Debt Issued | N/A | 80 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 23 | 500 | 724 | 776 |
| Other Financing Activity | -395 | -143 | 24 | 0 | -43 |
| Financing Cash Flow | $491 | $942 | $1,114 | $1,491 | $1,058 |
| Exchange Rate Effect | -95 | 4 | -3 | -53 | 23 |
| Beginning Cash Position | 21 | 10 | 4 | 2 | 67 |
| End Cash Position | 12 | 21 | 10 | 4 | 2 |
| Net Cash Flow | $-9 | $11 | $6 | $2 | $-65 |
| Free Cash Flow | |||||
| Operating Cash Flow | -405 | -935 | -1,105 | -1,436 | -1,145 |
| Free Cash Flow | -405 | -935 | -1,105 | -1,436 | -1,145 |